LumiraDx create an innovative point of care Platform that delivers portable and patient focused diagnostics, designed to transform community based healthcare.
All tests deliver lab-accurate results in minutes from small samples, enabling rapid clinical decision making and improved outcomes.
More than 30,000 Platforms have been placed globally, with over 3,000 Platforms in use across the UK in a variety of NHS and private healthcare settings. UK use includes decentralised community settings, hospitals, general practice, and pharmacies.
Platform Instrument
- Intuitive touch-screen interface
- Small and light, only 1.1kg
- Long-life rechargeable battery or mains power
- Results in minutes at the point of care
Test Strips
- Sample volumes of 20μL or less
- Multiple sample types, including fingerstick capillary blood and venous whole blood
- Room temperature storage (2-30℃)
- Microfluidic architecture minimises waste
Connectivity
LumiraDx connectivity solutions empower centralised insights and controls for your decentralised testing.
We work with you to define the best connectivity solution for your service, supporting integrations with various IT systems to drive deeper data sharing and intelligence within your organisation.
Further information on lumiradx.com
Brochure
LumiraDx Customer Services
Email: customerservices.uk@lumiradx.com
Telephone: +44 (0)1172 842 535
Case Study
Southern Health NHS Foundation Trust – Urgent Community Response and Frailty Virtual Ward
LumiraDx point of care testing supports rapid patient clinical assessment in the community, including helping to avoid unnecessary hospital admissions.
Read the full Southern Health case study
LumiraDx Partners with Everton in the community to Set Up England’s First Heart & Lung Screening Hub
• Run by Everton in the Community, the official charity of Everton Football Club, the Liverpool-based hub provides community support for individuals suffering from chronic breathlessness and other heart and lung-related conditions. The hub is made possible by unrestricted grant funding from AstraZeneca.
• Run on the LumiraDx Platform, the LumiraDx NT-proBNP test is a highly portable, lab-comparable diagnostic solution designed to improve access and ease of use for heart health checks, with results in only 12 minutes from a simple fingerstick sample.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.